News

Kaiser Permanente research published in The British Medical Journal showed two doses of Moderna COVID-19 vaccine were highly effective against all SARS-CoV-2 variants.

A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most serious complication of the disease for at least three years in some patients.

A new approach could help to reduce a serious adverse effect related to chimeric antigen receptor (CAR) T-cell therapy.

Researchers have set out to finally uncover exactly how the BCG vaccine works. A better understanding of the vaccination could help to design more effective tuberculosis vaccines.

Scientists from The Institute of Cancer Research are collaborating with the Cambridge-based immuno-oncology company Crescendo Biologics to develop a potential "next-generation" immunotherapy.

Researchers have developed a peptide vaccine that can alleviate conditions of dyslipidemia, defined as an abnormal level of lipids in the blood, and have proven its efficacy in obese mouse models.

A team of researchers has published an article in Nature Communications showing the potential of Find Cut-and-Transfer (FiCAT) technology as a state-of-the-art tool for gene writing to develop advanced therapies.

Researchers have found that intranasal vaccination provides broad-based protection against heterologous respiratory viruses in mice, while so-called systemic immunization, which uses an injection to elicit body-wide protection, did not.

Researchers have developed a new version of prime editing that can install or swap out gene-sized DNA sequences.

Researchers have found that memory B cells need the help of other memory cells to effectively defend the body against chronic viruses such as HIV, an important finding for vaccine design.